Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Pro Medicus Limited (ASX:PME) Wins 7-Year $27 Million US Contract

Australian software business Pro Medicus Limited (ASX: PME) announced Tuesday morning that it has won a 7-year deal worth $27 million with Partners Healthcare in the US.

Pro Medicus is a provider of radiology information systems, Picture Archiving and Communication Systems (PACS) and advanced visualization solutions.

Pro Medicus’ New US Contract

It has won a 7-year contract worth $27 million with Partners Healthcare, the largest health system in Massachusetts, it’s one of the largest health providers in North America.

The transaction licensing model contract will see Pro Medicus’ Visage 7 technology implemented at the Massachusetts General Hospital and Brigham and Women’s Hospital, there is scope to expand to other Partners’ hospitals in the future.

This deal has repositioned us in the market. Not only does it add to our rapidly growing North American footprint,” Pro Medicus CEO Dr Sam Hupert said.

“We now have two out of the top four US hospitals standardising on our platform, which we see a catalyst for growth in both North American and other global markets.”

The Pro Medicus share price was up almost 6% in early trade in response to this news.

Read Next: 3 Proven ASX Shares

The Rask Group Pty Ltd has issued its latest investing research report on 3 proven ASX dividend + growth sharesClick here to access the free report. No credit card or payment required. (sponsored)

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content